文献速递心境障碍

支持性正念认知疗法自助与支持性认知行为疗法自助治疗成人抑郁的成本效果比较:LIGHTMind随机临床试验

Clinical Effectiveness and Cost-Effectiveness of Supported Mindfulness-Based Cognitive Therapy Self-help Compared With Supported Cognitive Behavioral Therapy Self-help for Adults Experiencing Depression: The Low-Intensity Guided Help Through Mindfulness (LIGHTMind) Randomized Clinical Trial.
PubMed 文献 · JAMA Psychiatry · 2023-01-01

该随机临床试验纳入410名轻中度抑郁成人,比较治疗师支持的MBCT自助与CBT自助。16周时MBCT组PHQ-9评分较CBT组多降低1.5分(95%CI,-2.6至-0.4;d=-0.36),且成本效果概率超过95%。

要点

  • 治疗师支持的MBCT自助在16周时降低抑郁严重度优于CBT自助。
  • MBCT自助相对于CBT自助具有成本效果的概率超过95%。
  • 两组严重不良事件均判定与研究无关。

核心结论

  • 在轻中度抑郁成人中,治疗师支持的MBCT自助在临床有效性和成本效果上均优于标准推荐的治疗师支持CBT自助。

研究设计与样本

  • 采用评估者和参与者盲法的优势性随机临床试验,按中心和抑郁严重度分层1:1在线分配,比较治疗师支持的MBCT自助与CBT自助。
  • 共评估600名IAPT服务来访者,最终纳入410名符合轻中度抑郁诊断标准的成人。

主要发现

  • 410名随机参与者中255名(62.2%)为女性,年龄中位数(IQR)为32(25-45)岁。
  • 16周时MBCT自助组(n=204)PHQ-9平均(SD)评分为7.2(4.8),CBT自助组(n=206)为8.6(5.5)。
  • MBCT自助相对于CBT自助具有成本效果的概率超过95%。
  • 次要结局的组间效应方向与假设一致,但大多无统计学显著性;报告3例严重不良事件,均判定与研究无关。

关键数值与推荐

  • 主要结局为随机化后16周的患者健康问卷(PHQ-9)评分。
  • 主要分析为意向性治疗分析,并对治疗分组设盲。

临床怎么用

  • 对于初级保健服务中的轻中度抑郁成人,可常规提供治疗师支持的MBCT自助。

局限性

  • 次要结局的组间效应大多无统计学显著性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Depression is prevalent. Treatment guidelines recommend practitioner-supported cognitive behavioral therapy self-help (CBT-SH) for mild to moderate depression in adults; however, dropout rates are high. Alternative approaches are required. OBJECTIVE: To determine if practitioner-supported mindfulness-based cognitive therapy self-help (MBCT-SH) is superior to practitioner-supported CBT-SH at reducing depressive symptom severity at 16 weeks postrandomization among patients with mild to moderate depression and secondarily to examine if practitioner-supported MBCT-SH is cost-effective compared with practitioner-supported CBT-SH. DESIGN, SETTING, AND PARTICIPANTS: This was an assessor- and participant-blinded superiority randomized clinical trial with 1:1 automated online allocation stratified by center and depression severity comparing practitioner-supported MBCT-SH with practitioner-supported CBT-SH for adults experiencing mild to moderate depression. Recruitment took place between November 24, 2017, and January 31, 2020. The study took place in 10 publicly funded psychological therapy services in England (Improving Access to Psychological Therapies [IAPT]). A total of 600 clients attending IAPT services were assessed for eligibility, and 410 were enrolled. Participants met diagnostic criteria for mild to moderate depression. Data were analyzed from January to October 2021. INTERVENTIONS: Participants received a copy of either an MBCT-SH or CBT-SH workbook and were offered 6 support sessions with a trained practitioner. MAIN OUTCOMES AND MEASURES: The preregistered primary outcome was Patient Health Questionnaire (PHQ-9) score at 16 weeks postrandomization. The primary analysis was intention-to-treat with treatment arms masked. RESULTS: Of 410 randomized participants, 255 (62.2%) were female, and the median (IQR) age was 32 (25-45) years. At 16 weeks postrandomization, practitioner-supported MBCT-SH (n = 204; mean [SD] PHQ-9 score, 7.2 [4.8]) led to significantly greater reductions in depression symptom severity compared with practitioner-supported CBT-SH (n = 206; mean [SD] PHQ-9 score, 8.6 [5.5]), with a between-group difference of -1.5 PHQ-9 points (95% CI, -2.6 to -0.4; P = .009; d = -0.36). The probability of MBCT-SH being cost-effective compared with CBT-SH exceeded 95%. However, although between-group effects on secondary outcomes were in the hypothesized direction, they were mostly nonsignificant. Three serious adverse events were reported, all deemed not study related. CONCLUSIONS AND RELEVANCE: In this randomized clinical trial, practitioner-supported MBCT-SH was superior to standard recommended treatment (ie, practitioner-supported CBT-SH) for mild to moderate depression in terms of both clinical effectiveness and cost-effectiveness. Findings suggest that MBCT-SH for mild to moderate depression should be routinely offered to adults in primary care services. TRIAL REGISTRATION: isrctn.org Identifier: ISRCTN13495752.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Strauss C, Bibby-Jones AM, Jones F, et al. Clinical Effectiveness and Cost-Effectiveness of Supported Mindfulness-Based Cognitive Therapy Self-help Compared With Supported Cognitive Behavioral Therapy Self-help for Adults Experiencing Depression: The Low-Intensity Guided Help Through Mindfulness (LIGHTMind) Randomized Clinical Trial. JAMA Psychiatry. 2023. PMID: 36947058. doi:10.1001/jamapsychiatry.2023.0222

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。